VAUGHAN, ON, May 14, 2019 /PRNewswire/ - CannTrust Holdings Inc. ("CannTrust" or the "Company", (TSX: TRST) (NYSE: CTST) today released its financial results for the first quarter ended March 31, 2019. "The... read more →
MariMed Announces Strong Q1 2019 Earnings, Revenue and Adjusted EBITDA Jump 69% and 76% Respectively
Significant improvement in operating performance – Revenue up 69%; Adjusted EBITDA up 76% Planned consolidation of cannabis operations under MariMed banner advancing on schedule The launch of MariMed Hemp operations including the development of CBD brands and products Conversion of debt investment... read more →
Q3 2019 net revenue was $10 million, a 382% increase from Q3 2018 ($2.1 million) and a 29% increase from Q2 2019 ($7.7 million). Sales revenue from adult-use recreational markets increased... read more →
Key highlights of second quarter of 2019 fiscal year Gross revenue increased 1,269% as compared to the second quarter of fiscal 2018 and increased144% from the first quarter of fiscal... read more →
Epidiolex® (cannabidiol) oral solution (CV), first FDA-approved plant-derived cannabinoid medicine, launched in the U.S. in November to high awareness and demand GW moves to a new fiscal year-end beginning January 1,... read more →
Net revenue growth due to first shipments of adult-use recreational product during the period Consists of gross revenue of $14.4 million less excise taxes and returns of $2.0 million Adjusted Gross Margin (a... read more →
Net revenue of $21.7 million up 63% from prior quarter on initial sales to Canadian adult-use market; adjusted gross profit of $10.2 million To accelerate the production ramp-up post-Health Canada approvals, yields were... read more →
Results to August 31, 2018 showcase a Canadian leader in low-cost cultivation while growing high-quality indoor product MONCTON, NB, Dec. 14, 2018 /PRNewswire/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), the parent... read more →
Sales of $5.2 million for adult-use cannabis during the first two weeks of legalization in Canada Creation of Truss, a partnership with Molson Coors Canada in support of the Company’s... read more →
TORONTO, Dec. 7, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) www.libertyhealthsciences.com("Liberty" or the "Company"), a provider of high quality cannabis, announced today that they experienced a significant increase in... read more →